{"product_id":"axchgh-frag-176-191","title":"hGH frag (176-191) 5mg","description":"\u003ch1\u003eWhat is hGH Frag 176-191?\u003c\/h1\u003e\n\u003cp class=\"p1\"\u003ehGH Fragment 176-191 is a synthetic peptide fragment constructed from the amino acid sequence 176-191 of the C-terminal portion of human growth hormone (hGH). This molecule was developed to separately investigate the lipolytic properties attributed to certain segments of GH, without reproducing the full physiological profile of growth hormone. In scientific literature, hGH Frag 176-191 has been considered a model compound for studies on lipolysis, lipid metabolism, and energy balance.\u003c\/p\u003e\n\n\u003c!-- Изображение --\u003e\n\n\u003cp class=\"p1\"\u003eUnlike full-length hGH, hGH Frag 176-191 is not associated with a significant increase in IGF-1 and does not demonstrate the typical growth effects on tissues and organs. Instead, in experimental models, the peptide has been associated with stimulating fatty acid breakdown and limiting lipogenesis processes. Therefore, it is used as a research tool in studying mechanisms related to fat metabolism and metabolic regulation.\u003c\/p\u003e\n\n\u003cp class=\"p1\"\u003e \u003c\/p\u003e\n\n\u003ch2\u003eObservations on HGH Frag 176-191\u003c\/h2\u003e\n\u003cp class=\"p1\"\u003eIn published scientific literature, HGH Frag 176-191 has been investigated in relation to the following:\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\u003cp class=\"p1\"\u003eStimulation of lipolysis – aids in the breakdown of fatty acids in adipocyte models\u003c\/p\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cp class=\"p1\"\u003eInhibition of lipogenesis – associated with limiting the accumulation of new fat deposits\u003c\/p\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cp class=\"p1\"\u003eRegulation of body weight – considered a potential model for metabolic modulation\u003c\/p\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cp class=\"p1\"\u003eMaintenance of lean muscle mass – without the pronounced anabolic profile characteristic of full GH\u003c\/p\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cp class=\"p1\"\u003eReduction of visceral adipose tissue – observed in models related to obesity\u003c\/p\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cp class=\"p1\"\u003eInsulin sensitivity – effects described in some preclinical studies\u003c\/p\u003e\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003cp\u003e \u003c\/p\u003e\n\n\u003ch2\u003eAdministration and Dosage\u003c\/h2\u003e\n\u003cp\u003eIn scientific publications and experimental protocols, amounts in the range of 250-500 μg daily are found, typically administered subcutaneously under controlled research conditions and often divided into 1-2 applications. The peptide is most often considered in short-term research models focused on lipolytic mechanisms. hGH Frag 176-191 is among the more hydrophobic peptides, which may limit its solubility and typically requires using the entire solution.\u003c\/p\u003e\n\n\u003cp\u003eFor 5 mg + 3 ml bacteriostatic water:\u003c\/p\u003e\n\u003cp\u003eConcentration = 1.67 mg\/ml → 0.06 ml = 100 μg\u003c\/p\u003e\n\u003cp\u003eExample values:\u003c\/p\u003e\n\u003cp\u003e0.06 ml = 100 μg\u003c\/p\u003e\n\u003cp\u003e0.12 ml = 200 μg\u003c\/p\u003e\n\u003cp\u003e0.18 ml = 300 μg\u003c\/p\u003e\n\u003cp\u003e0.24 ml = 400 μg\u003c\/p\u003e\n\n\u003ch2\u003e\u003c\/h2\u003e\n\n\u003ch2\u003eScientific Data\u003c\/h2\u003e\n\u003cp class=\"p1\"\u003eHGH Frag 176-191 has been primarily the subject of preclinical studies, as well as limited clinical observations. The main scientific data described include:\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\u003cp class=\"p1\"\u003eIncreased lipolytic activity in adipocyte cultures and experimental models\u003c\/p\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cp class=\"p1\"\u003eReduction of total and visceral adipose tissue without significant changes in IGF-1 levels\u003c\/p\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cp class=\"p1\"\u003eLack of a distinct effect on glucose homeostasis at low experimental quantities\u003c\/p\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cp class=\"p1\"\u003eAbsence of observed influence on organ and tissue growth\u003c\/p\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cp class=\"p1\"\u003eImprovements in lipid metabolism and energy efficiency in some preclinical models\u003c\/p\u003e\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\n\u003ch2\u003eApplication in Sports and Research Settings\u003c\/h2\u003e\n\u003cp class=\"p1\"\u003eHGH Fragment 176-191 is listed by WADA as a controlled substance and is not permitted for use by professional athletes. In laboratory and academic contexts, the peptide is used to study lipolytic processes, energy metabolism, and models related to metabolic syndrome, obesity, and insulin resistance.\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\u003cp class=\"p1\"\u003eModel for studying mechanisms related to fat tissue reduction\u003c\/p\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cp class=\"p1\"\u003eStudies on insulin sensitivity, lipid metabolism, and energy balance\u003c\/p\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cp class=\"p1\"\u003eInvestigation of potential interaction with other peptides involved in metabolic regulation\u003c\/p\u003e\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003cp\u003e \u003c\/p\u003e\n\n\u003ch2\u003ePossible Side Effects\u003c\/h2\u003e\n\u003cp class=\"p1\"\u003eIn the available scientific literature, HGH Frag 176-191 is generally described as well-tolerated within research settings. Observed reactions are primarily mild and transient:\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\u003cp class=\"p1\"\u003eLocal redness or discomfort at the experimental application site\u003c\/p\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cp class=\"p1\"\u003eMild fatigue or drowsiness\u003c\/p\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cp class=\"p1\"\u003eHeadache at higher experimental quantities\u003c\/p\u003e\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003cp class=\"p1\"\u003eNo serious adverse reactions at research quantities are reported in the published data. The described effects are primarily dose-dependent, temporary, and dependent on the conditions of the specific model.\u003c\/p\u003e\n\n\u003cp class=\"p1\"\u003e\u003cem\u003eThe information is based on scientific literature and is for educational purposes. It does not constitute medical advice and is not intended for diagnosis, treatment, prevention, or use in humans or animals.\u003c\/em\u003e\u003c\/p\u003e","brand":"My Store","offers":[{"title":"5mg","offer_id":53386106339671,"sku":"PP-HGH-FRAG-5MG","price":49.0,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/1011\/8902\/6135\/files\/hgh-frag-176-191br5mg-3748012_c7410536-5990-4c10-9435-3a63dfd65ce5.png?v=1779544815","url":"https:\/\/purepeptide.eu\/products\/axchgh-frag-176-191","provider":"PurePeptide","version":"1.0","type":"link"}